Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease.

Kundu N, Domingues CC, Chou C, Ahmadi N, Houston S, Jerry DJ, Sen S. Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease. J Am Heart Assoc. 2017 Apr 01; 6(4).

View in: PubMed

subject areas

Animals
Cyclin-Dependent Kinase Inhibitor p21
Diabetes Mellitus, Experimental
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetic Angiopathies
Disease Models, Animal
Endothelial Progenitor Cells
Gene Silencing
Hindlimb
Ischemia
Mice
Mice, Inbred C57BL
Mice, Inbred NOD
Mice, Knockout
Muscle, Skeletal
Neovascularization, Physiologic
Nitric Oxide Synthase Type III
Peripheral Vascular Diseases
Platelet Endothelial Cell Adhesion Molecule-1
Regional Blood Flow
Tumor Suppressor Protein p53
Vascular Endothelial Growth Factor A

authors with profiles

D Joseph Jerry BS, MS, PhD